Human gene patent eligibility scrutinized at US Senate hearing
By Nick Robertson ( July 14, 2026, 22:56 GMT | Insight) -- A Senate Judiciary Committee hearing Tuesday on a proposal to broaden patent eligibility focused on how to limit consequences for human genome researchers amid criticism the bill could go too far. Sponsors of the Patent Eligibility Restoration Act said much of the work ahead will involve helping their Senate colleagues understand the complexities of patent law.A proposal to reform patent eligibility law reached its largest platform yet Tuesday with a hearing before the full Senate Judiciary Committee. The Patent Eligibility Restoration Act (PERA) aims to clarify eligibility law by codifying the numerous judicial exceptions to 35 USC § 101 handed down by the Supreme Court over the last 15 years....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.